FindTrial
Sign In

Dexmedetomidine vs Remifentanil target-controlled infusion for conscious sedation for awake intubation with the Shikani Optical Stylet

Dexmedetomidine vs Remifentanil target-controlled infusion for conscious sedation for awake intubation with the Shikani Optical Stylet

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-13003052
Enrollment
Unknown
Registered
2013-02-04
Start date
2013-02-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anesthesia management for awake intubation with the Shikani Optical Stylet

Interventions

Group D:dexmedetomidnie for conscious sedation
Control:remifentanil

Sponsors

Peking University Third Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients with cervical trauma or severe cervical spondylotic myelopathy for selective operation; ASA I-III.

Exclusion criteria

Exclusion criteria: Coronary disease; Second-degree or third-degree atrioventricular block; History of epilepsy

Design outcomes

Primary

MeasureTime frame
blood pressure;heart rate;—

Contacts

Public ContactLi Min
liminanesth@yahoo.com.cn+86 13522757239

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 12, 2026